Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Aruffo

Showing results (191-200 of 201) with videos related to

Pageof 21
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|August 18, 2000
Constitutive expression of functional 4-1BB (CD137) ligand on carcinoma cellsH R Salih, S G Kosowski, V F Haluska, et al.
Transactions of the Association of American Physicians|January 11, 1991
Expression cloning and characterization of a porcine renal calcitonin receptorH Y Lin, T L Harris, M S Flannery, et al.
Immunity|June 1, 1995
In the absence of a CD40 signal, B cells are tolerogenicJ E Buhlmann, T M Foy, A Aruffo, et al.
Journal of Medicinal Chemistry|November 5, 1997
Sulfated galactocerebrosides as potential antiinflammatory agentsA Marinier, A Martel, J Banville, et al.
Transplantation|June 30, 1998
Prolonged acceptance of concordant and discordant xenografts with combined CD40 and CD28 pathway blockadeE T Elwood, C P Larsen, H R Cho, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 20, 1998
The role of the CD40 pathway in alloantigen-induced hyporesponsiveness in vivoM Niimi, T C Pearson, C P Larsen, et al.
Nature|May 30, 1996
Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathwaysC P Larsen, E T Elwood, D Z Alexander, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 8, 1997
BMS-190394, a selectin inhibitor, prevents rat cutaneous inflammatory reactionsG Todderud, X Nair, D Lee, et al.
The Journal of Experimental Medicine|July 7, 1997
4-1BB costimulatory signals preferentially induce CD8+ T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responsesW W Shuford, K Klussman, D D Tritchler, et al.
The Journal of Experimental Medicine|November 1, 1995
An essential role for gp39, the ligand for CD40, in thymic selectionT M Foy, D M Page, T J Waldschmidt, et al.
Pageof 21

Showing results (191-200 of 201) with videos related to

Sort By:
Pageof 21
Journal of Immunology (Baltimore, Md. : 1950)|August 18, 2000
Constitutive expression of functional 4-1BB (CD137) ligand on carcinoma cellsH R Salih, S G Kosowski, V F Haluska, et al.
Transactions of the Association of American Physicians|January 11, 1991
Expression cloning and characterization of a porcine renal calcitonin receptorH Y Lin, T L Harris, M S Flannery, et al.
Immunity|June 1, 1995
In the absence of a CD40 signal, B cells are tolerogenicJ E Buhlmann, T M Foy, A Aruffo, et al.
Journal of Medicinal Chemistry|November 5, 1997
Sulfated galactocerebrosides as potential antiinflammatory agentsA Marinier, A Martel, J Banville, et al.
Transplantation|June 30, 1998
Prolonged acceptance of concordant and discordant xenografts with combined CD40 and CD28 pathway blockadeE T Elwood, C P Larsen, H R Cho, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 20, 1998
The role of the CD40 pathway in alloantigen-induced hyporesponsiveness in vivoM Niimi, T C Pearson, C P Larsen, et al.
Nature|May 30, 1996
Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathwaysC P Larsen, E T Elwood, D Z Alexander, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 8, 1997
BMS-190394, a selectin inhibitor, prevents rat cutaneous inflammatory reactionsG Todderud, X Nair, D Lee, et al.
The Journal of Experimental Medicine|July 7, 1997
4-1BB costimulatory signals preferentially induce CD8+ T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responsesW W Shuford, K Klussman, D D Tritchler, et al.
The Journal of Experimental Medicine|November 1, 1995
An essential role for gp39, the ligand for CD40, in thymic selectionT M Foy, D M Page, T J Waldschmidt, et al.
Pageof 21